drug combination morphinenaltrexone trade name embeda opioid combination pain medication developed king pharmaceuticals use moderate severe active ingredients morphine sulfate naltrexone hydrochloride morphine opioid receptor agonist naltrexone opioid receptor antagonist schedule ii controlled substance intended longterm pain caused malignancy lower tiers pain management ladder already exhausted medications oxycodone would otherwise king pharmaceuticals temporarily recalled embeda complaints fda regard king pharmaceuticals omitting information regarding potentially fatal reaction crushed swallowed also making unsubstantiated claims regarding embedas reduced abuse analgesicrelated article stub help wikipedia expanding httpsenwikipediaorgwikimorphinenaltrexone